Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Vincent

Showing results (211-220 of 952) with videos related to

Pageof 96
Sort By:
Critical Care (London, England)|August 12, 2016
Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed?Jean-Louis Vincent, Daniel De Backer
The Lancet. Respiratory Medicine|April 10, 2020
Understanding pathways to death in patients with COVID-19Jean-Louis Vincent, Fabio S Taccone
Critical Care (London, England)|March 6, 2003
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrineJean-Louis Vincent, Daniel de Backer,
Critical Care Medicine|April 9, 2005
Decreased mortality with the use of the pulmonary artery catheter?Daniel De Backer, Jean-Louis Vincent
Critical Care (London, England)|November 10, 2015
Difficulty interpreting the results of some trials: the case of therapeutic hypothermia after pediatric cardiac arrestJean-Louis Vincent, Fabio S Taccone
Nature Reviews. Nephrology|November 8, 2016
Sepsis: Vasopressin: a first-line agent for septic shock?Jean-Louis Vincent, Emiel H Post
Intensive Care Medicine|March 9, 2016
Early goal-directed therapy: do we have a definitive answer?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|February 15, 2020
The authors replyJean-Louis Vincent, Carlos A Santacruz
American Journal of Respiratory and Critical Care Medicine|June 18, 2019
Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|May 11, 2002
Platelet function in sepsisJean-Louis Vincent, Arino Yagushi, Olivier Pradier
Pageof 96

Showing results (211-220 of 952) with videos related to

Sort By:
Pageof 96
Critical Care (London, England)|August 12, 2016
Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed?Jean-Louis Vincent, Daniel De Backer
The Lancet. Respiratory Medicine|April 10, 2020
Understanding pathways to death in patients with COVID-19Jean-Louis Vincent, Fabio S Taccone
Critical Care (London, England)|March 6, 2003
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrineJean-Louis Vincent, Daniel de Backer,
Critical Care Medicine|April 9, 2005
Decreased mortality with the use of the pulmonary artery catheter?Daniel De Backer, Jean-Louis Vincent
Critical Care (London, England)|November 10, 2015
Difficulty interpreting the results of some trials: the case of therapeutic hypothermia after pediatric cardiac arrestJean-Louis Vincent, Fabio S Taccone
Nature Reviews. Nephrology|November 8, 2016
Sepsis: Vasopressin: a first-line agent for septic shock?Jean-Louis Vincent, Emiel H Post
Intensive Care Medicine|March 9, 2016
Early goal-directed therapy: do we have a definitive answer?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|February 15, 2020
The authors replyJean-Louis Vincent, Carlos A Santacruz
American Journal of Respiratory and Critical Care Medicine|June 18, 2019
Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|May 11, 2002
Platelet function in sepsisJean-Louis Vincent, Arino Yagushi, Olivier Pradier
Pageof 96